Anthony L. Boral, Chief Medical Officer at Blueprint Medicines Corp (BPMC), sold 20,000 shares at $76.87 ($1.5M) on 2019-12-17, disclosed to the SEC on 2019-12-19.
Open-market sale of $1.5M BPMC by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.11 | 3,930 | $299K | 19.5% |
| 2 | $76.11 | 3,930 | $299K | 19.5% |
| 3 | $76.87 | 6,070 | $467K | 30.5% |
| 4 | $76.87 | 6,070 | $467K | 30.5% |
| Total | $76.57 avg | 20,000 | $1.5M | 100% |
| Filing → |
| BPMC | SELL | 2020-09-21 | $1.9M | — | Filing → |
| BPMC | SELL | 2020-03-11 | $28K | — | Filing → |
| BPMC | SELL | 2019-08-22 | $801K | — | Filing → |